Firmonertinib Combined With Definitive Radiotherapy in Stage III Unresectable EGFR Uncommon Mutant Pulmonary Adenocarcinoma

Abroad (travel likely)RecruitingPHASE2

Conditions

NSCLC (Non-small Cell Lung Carcinoma) · Stage III · EGFR Uncommon Mutations

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Hunan Cancer Hospital, Changsha, Hunan, China
Contact: Study coordinator (Huai Liu) · liuhuai@hnca.org.cn · 0731-89762321

Study leads

Huai Liu, M.Med.
Principal Investigator
Hunan Cancer Hospital
Xingxiang Pu, M.D.
Principal Investigator
Hunan Cancer Hospital

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Stereotactic Body Radiation Therapy Planning With Artificial Intelligence-Directed Dose Recommendation for Treatment of Primary or Metastatic Lung Tumors, RAD-AI Study

Lung Carcinoma · Lung Non-Small Cell Carcinoma · Metastatic Malignant Neoplasm in the Lung

Abroad (travel likely)Recruiting

Chicago, United States

Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations

Non-Small-Cell Lung Cancer · Metastatic Non-Small-Cell Lung Cancer · Advanced Non-Small-Cell Lung Cancer

Abroad (travel likely)RecruitingPHASE3

Los Angeles, United States · Sacramento, United States

Sotorasib in Combination With Trastuzumab Deruxtecan for the Treatment of Locally Advanced and Metastatic Non-small Cell Lung Cancer With a KRAS G12C Mutation

Locally Advanced Lung Non-Small Cell Carcinoma · Metastatic Lung Non-Small Cell Carcinoma · Stage III Lung Cancer AJCC v8

Abroad (travel likely)RecruitingPHASE1, PHASE2

Sacramento, United States · Tampa, United States

Pulmonary Rehabilitation in Advanced Lung Cancer Survivors

Non-small Cell Lung Cancer Stage III · Non-small Cell Lung Cancer Stage IV · Non-small Cell Lung Cancer

Abroad (travel likely)RecruitingPHASE2

Cleveland, United States